The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

Igm Biosciences (IGMS) has disclosed a new risk, in the Costs category. Igm Biosciences faces a potential risk if the anticipated financial and ...

In trading on Monday, shares of the iShares Expanded Tech Sector ETF (Symbol: IGM) entered into oversold territory, changing hands as low as $92.9302 per share. We define oversold territory using ...

IGM Financial Inc. (TSE:IGM – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$43.75 and traded as high as C$43 ...

A 3-month-old child from Bhiwandi has died, allegedly due to malnutrition, sparking an investigation. Despite receiving ...

In a report released today, Michael Ulz from Morgan Stanley maintained a Sell rating on IGM Biosciences (IGMS – Research Report), with a price ...

In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on IGM Biosciences (IGMS – Research Report), with a ...

If you wish to manage your notification settings from this browser you will need to update your browser's settings for this site. Just click button below and allow notifications for this site Note ...

With the Canadian market facing uncertainties due to potential tariffs and political shifts, investors are increasingly adopting a defensive stance. In this environment, dividend stocks can offer a ...

High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...